Candy Robinson
Impact in
- Immunology and Allergy top 5%
- Cell Adhesion Molecules Research
- Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
-
- Angiogenesis and VEGF in Cancer 9
- Muscle Physiology and Disorders 3
- Co-authors
- Bruce Ruggeri (9 shared papers)Peter J. Gillies (10 shared papers)Janet S. Kerr (2 shared papers)Roseanne S. Wexler (2 shared papers)Joseph A. Madri (1 shared paper)Cecília Garlanda (1 shared paper)Marie D. Burdick (1 shared paper)Robert M. Strieter (1 shared paper)
- Journals
- Bioorganic & Medicinal Chemistry Letters (5 papers)Experimental and Molecular Pathology (3 papers)Atherosclerosis (2 papers)Journal of Medicinal Chemistry (2 papers)Microvascular Research (2 papers)
- Partner nations
- United StatesAustraliaItaly
In The Last Decade
Candy Robinson
30 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 105
- Immunology and Allergy 125
- Genetics 198
- Hematology 175
- Molecular Biology 890
- Developmental Neuroscience 49
Countries citing papers authored by Candy Robinson
This map shows the geographic impact of Candy Robinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Candy Robinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Candy Robinson more than expected).
Fields of papers citing papers by Candy Robinson
This network shows the impact of papers produced by Candy Robinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Candy Robinson. The network helps show where Candy Robinson may publish in the future.
Co-authors
The 25 scholars most cited alongside Candy Robinson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Involvement of endothelial PECAM-1/CD31 in angiogenesis. | 1997 | 460 |
| 2 | 2007 | 202 | |
| 3 | 1998 | 166 | |
| 4 | 2004 | 139 | |
| 5 | 1986 | 99 | |
| 6 | 2006 | 88 | |
| 7 | 1998 | 71 | |
| 8 | 2003 | 57 | |
| 9 | 2004 | 53 | |
| 10 | The chemopreventive agent oltipraz possesses potent antiangiogenic activity in vitro, ex vivo, and in vivo and inhibits tumor xenograft growth. | 2002 | 33 |
| 11 | 1994 | 28 | |
| 12 | 1983 | 26 | |
| 13 | 1990 | 22 | |
| 14 | 1984 | 21 | |
| 15 | 1988 | 19 | |
| 16 | 2006 | 17 | |
| 17 | 1982 | 17 | |
| 18 | 2008 | 15 | |
| 19 | 2006 | 13 | |
| 20 | 1997 | 9 |
About Candy Robinson
Candy Robinson is a scholar working on Molecular Biology, Cell Biology, Surgery, Oncology and Pharmacology, having authored 30 papers that have together received 1.6k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (9 papers), Cholesterol and Lipid Metabolism (4 papers), Cell Adhesion Molecules Research (3 papers), Inflammatory mediators and NSAID effects (3 papers), Muscle Physiology and Disorders (3 papers), Cancer Treatment and Pharmacology (2 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Immunology and Allergy (125 citations), Genetics (198 citations), Hematology (175 citations), Molecular Biology (890 citations) and Developmental Neuroscience (49 citations). Candy Robinson has collaborated with scholars based in United States, Australia and Italy. Frequent co-authors include Bruce Ruggeri, Peter J. Gillies, Janet S. Kerr, Roseanne S. Wexler, Joseph A. Madri, Cecília Garlanda, Marie D. Burdick, Robert M. Strieter, Steven Μ. Albelda and June Rae Merwin. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Experimental and Molecular Pathology, Atherosclerosis, Journal of Medicinal Chemistry and Microvascular Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.